Cases & Articles

08/19/2025
Global Biometrics Excellence: A Decade-Long Partnership Driving Pharmaceutical Success
Executive SummaryGCP ClinPlus established a transformative decade-long partnership with a US biotech company, delivering comprehensive biostatistics and SAS programming capabilities that significantly...

08/19/2025
Case Study: Strategic Clinical Oversight Accelerates Oncology Approval
In the fast-paced field of oncology drug development, the addition of a new indication often presents complex regulatory, operational, and scientific challenges. In late 2024, ...

08/19/2025
Case Study: Scalable Programming Excellence with FSP
GCP ClinPlus Enhances Trial Delivery for a U.S.-Based Ophthalmology SponsorThe ChallengeDuring a critical phase of multiple ophthalmology trials, the sponsor faced fluctuating programming workloads ...

08/19/2025
Navigating the Statistical Challenges of Rare Disease Clinical Trials
By GCP ClinPlus Biostatistics TeamRare diseases collectively affect 300 million people worldwide, with more than 6,000 distinct disorders identified to date. Most are genetic (72%), predominantly ...

08/18/2025
Avoiding Rework: How Intelligent Programming Saves Time in the Later Trial Phase
In clinical trials, rework caused by inconsistent data structures, programming errors, or non - compliance with regulatory standards may delay submissions and increase budgets. By adopting proactive ...

08/18/2025
Biometrics in 2025: What Sponsors Need to Know Now
As we navigate 2025, the biometrics landscape is undergoing transformative changes that sponsors must understand to maintain competitive advantage. ..

For more information about what is cro in clinical research and what are cros, please feel free to contact us!

There are many clinical development companies, but we are one of the best choices for you.